Eastern Canadian Colorectal Cancer Consensus Conference: standards of care for the treatment of patients with rectal, pancreatic, and gastrointestinal stromal tumours and pancreatic neuroendocrine tumours

• Published in: Current oncology (Toronto) Vol. 20; no. 5; pp. e455 - 464
• Main Authors: Di Valentin, T, Biagi, J, Bourque, S, Butt, R, Champion, P, Chaput, V, Colwell, B, Cripps, C, Dorreen, M, Edwards, S, Falkson, C, Frechette, D, Gill, S, Goel, R, Grant, D, Hammad, N, Jeyakumar, A, L'espérance, M, Marginean, C, Maroun, J, Nantais, M, Perrin, N, Quinton, C, Rother, M, Samson, B, Siddiqui, J, Singh, S, Snow, S, St-Hilaire, E, Tehfe, M, Thirlwell, M, Welch, S, Williams, L, Wright, F, Goodwin, R
• Format: Journal Article
• Language: English
• Published: Canada Multimed Inc 01-10-2013
• Subjects: Practice Guideline; pancreatic neuroendocrine tumours; folfirinox; mccs; rectal cancer; palliative care; Consensus guideline; gastrointestinal stromal tumours
• ISSN: 1198-0052; 1718-7729; 1718-7729
• DOI: 10.3747/co.20.1638

The annual Eastern Canadian Colorectal Cancer Consensus Conference was held in Halifax, Nova Scotia, October 20-22, 2011. Health care professionals involved in the care of patients with colorectal cancer participated in presentation and discussion sessions for the purposes of developing the recommendations presented here. This consensus statement addresses current issues in the management of rectal cancer, including pathology reporting, neoadjuvant systemic and radiation therapy, surgical techniques, and palliative care of rectal cancer patients. Other topics discussed include multidisciplinary cancer conferences, treatment of gastrointestinal stromal tumours and pancreatic neuroendocrine tumours, the use of folfirinox in pancreatic cancer, and treatment of stage ii colon cancer.